Incidence, risk factors, and outcomes of respiratory related hospitalizations in older patients with COPD, asthma, and bronchiectasis
- PMID: 40596166
- PMCID: PMC12216934
- DOI: 10.1038/s41598-025-07197-x
Incidence, risk factors, and outcomes of respiratory related hospitalizations in older patients with COPD, asthma, and bronchiectasis
Abstract
The increasing prevalence of chronic respiratory diseases among older adults significantly affects morbidity and mortality rates. Hospitalizations from exacerbations and acute respiratory infections (ARIs) pose a substantial burden on healthcare systems. This study aimed to estimate the nationwide incidence of such hospitalizations among older adults with chronic respiratory diseases, identify risk factors, and assess outcomes like intensive care needs and mortality. Utilizing data from the National Health Insurance Service senior cohort (2016-2017), we analyzed patients aged 60 and above diagnosed with chronic obstructive pulmonary disease, asthma, or bronchiectasis. We followed hospitalization rates over two years, employing Cox regression models to identify predictors for hospitalizations. Out of 117,793 patients, 16,024 (13.6%) patients had overlapping respiratory diseases with COPD, asthma and/or bronchiectasis. Of the total population, 9.6% were hospitalized due to exacerbations or ARIs, showing an incidence rate of 10.6 per 100 patient-years. Notably, patients with multiple respiratory diseases had hospitalization rates over 20%. Of the 24,186 hospitalizations, 6.5% necessitated intensive care, and 2.2% were fatal. Increased risk of hospitalization was associated with being 85 or older, having multiple respiratory conditions, and taking certain medications such as antipsychotics and anti-dementia drugs. This study reveals a notable rate of hospitalization due to exacerbations or ARIs among older adults with chronic respiratory diseases, with age, multiple conditions, and specific medications being major risk factors. The findings underscore the need for targeted preventive strategies and careful management of this vulnerable population.
Keywords: Acute respiratory infections; Asthma; Bronchiectasis; Chronic obstructive pulmonary disease; Hospitalization; Older adult.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was performed in accordance with the Declaration of Helsinki. This human study was approved by the Institutional Review Board of Seoul National University-approval: IRB number E2303/004 001. The requirement for informed consent to participate was waived by the Seoul National University Institutional Review Board due to the retrospective nature of the study. Adult participant consent was not required because of the retrospective cohort design, which utilized de-identified claims data. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Self-management for bronchiectasis.Cochrane Database Syst Rev. 2018 Feb 7;2(2):CD012528. doi: 10.1002/14651858.CD012528.pub2. Cochrane Database Syst Rev. 2018. PMID: 29411860 Free PMC article.
-
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4. Cochrane Database Syst Rev. 2016. PMID: 27990628 Free PMC article.
-
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2. Cochrane Database Syst Rev. 2017. PMID: 28777450 Free PMC article.
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
References
-
- Soriano, J. B. et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir. Med.3, 443–450 (2015). - PubMed
-
- May, S. M. & Li, J. T. In Allergy and Asthma Proceedings. 4.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical